Brown Gary C, Brown Melissa M, Sharma Sanjay
Retina Service, Wills Eye Hospital, Jefferson Medical College, Philadelphia PA, USA.
Ocul Immunol Inflamm. 2003 Sep;11(3):157-70. doi: 10.1076/ocii.11.3.157.17355.
Value-based medicine is the practice of medicine emphasizing the value received from an intervention. Value is measured by objectively quantifying: 1) the improvement in quality of life and/or 2) the improvement in length of life conferred by an intervention. Evidence-based medicine often measures the improvement gained in length of life, but generally ignores the importance of quality of life improvement or loss. Value-based medicine incorporates the best features of evidence-based medicine and takes evidence-based data to a higher level by incorporating the quality of life perceptions of patients with a disease in concerning the value of an intervention. Inherent in value-based medicine are the costs associated with an intervention. The resources expended for the value gained in value-based medicine is measured with cost-utility analysis in terms of the US dollars/QALY (money spent per quality-adjusted life-year gained). A review of the current status and the likely future of value-based medicine is addressed herein.
价值医疗是一种强调从干预措施中获得价值的医疗实践。价值通过客观量化来衡量:1)生活质量的改善和/或2)干预措施带来的寿命延长。循证医学通常衡量寿命延长方面的改善,但一般忽略生活质量改善或下降的重要性。价值医疗融合了循证医学的最佳特性,并通过纳入患有某种疾病的患者对干预措施价值的生活质量认知,将循证数据提升到更高水平。价值医疗内在包含与干预措施相关的成本。在价值医疗中,为所获得的价值而消耗的资源通过成本效益分析以美元/质量调整生命年(每获得一个质量调整生命年所花费的金钱)来衡量。本文探讨了价值医疗的现状及可能的未来发展。